Which Vaccines are Safe for Multiple Myeloma? | Inciteful Med
Published: | Updated:
Multiple myeloma patients should only receive inactivated vaccines, such as the flu shot, COVID-19 vaccines, and Shingrix, which are safe and highly recommended. Live vaccines like MMR and yellow fever are dangerous due to a weakened immune system and must be strictly avoided.
Key Takeaways
- • Inactivated vaccines, including the injectable flu shot, COVID-19 vaccines, and Shingrix, are safe and strongly recommended for multiple myeloma patients.
- • Live vaccines such as MMR, FluMist, and yellow fever are dangerous and must be strictly avoided due to your weakened immune system.
- • Household members should stay fully vaccinated to create a protective barrier around you, a strategy known as cocooning.
- • The timing of your vaccines is critical, as recent treatments like stem cell transplants or CAR-T therapy may require delaying vaccines until your immune system recovers.
To protect yourself from infections, inactivated vaccines—like the flu shot, COVID-19 vaccines, pneumococcal vaccines, and the Shingrix shingles vaccine—are safe and highly recommended for individuals with multiple myeloma [1]. You must avoid all live vaccines, such as the MMR (measles, mumps, rubella), yellow fever, and the older Zostavax shingles vaccine [1]. Live vaccines contain weakened germs that can cause the very infections they are meant to prevent in someone with a compromised immune system [2].
Why Your Immune System Needs Extra Support
Multiple myeloma and its treatments—including chemotherapy, immunomodulatory drugs, and monoclonal antibodies—significantly weaken your immune system [3][2]. This state of being immunocompromised (having a weakened immune system) increases your risk for catching infections [1]. To help keep you healthy, international experts strongly recommend a robust vaccination strategy [1]. However, because your immune system works differently right now, the exact type of vaccine you receive is critical.
The Danger of Live Vaccines
Live-attenuated vaccines contain a weakened, but living, form of a virus or bacteria. In a healthy person, this weakened germ safely triggers an immune response without causing illness [4][5]. But if you have multiple myeloma, your immune system—specifically your T-cells and antibody levels—may not be strong enough to control even a weakened germ [6][7]. As a result, the germ can multiply and cause a severe, potentially life-threatening infection [2][8].
For this reason, live vaccines are dangerous and contraindicated (must be avoided) while you are immunocompromised [9][1].
Examples of live vaccines you must avoid include:
- MMR (measles, mumps, rubella)
- Yellow fever
- FluMist: The nasal spray flu vaccine [1]
- Oral typhoid or rotavirus vaccines [1]
- Zostavax: The older live shingles vaccine. Note: This vaccine was discontinued in the US in 2020, but you must avoid it if it is offered internationally [1].
Safe, Highly Recommended Inactivated Vaccines
Inactivated and recombinant vaccines are safe for you. These vaccines use dead germs, or just small pieces or proteins from the germ, to teach your body how to fight it [4][10]. Because there is no live pathogen, these vaccines cannot multiply and are physically incapable of causing the disease [11][12].
Highly recommended safe vaccines include:
- Flu shot: The injectable form, not the nasal spray.
- COVID-19 vaccines: Both the mRNA vaccines and protein-based vaccines are safe because they do not contain live virus. Periodic booster doses are necessary to help you maintain your antibody levels [13][14].
- Pneumococcal vaccines: Protects against pneumonia.
- Shingrix: This is the recombinant (inactivated) shingles vaccine. It is the preferred, safe way to prevent shingles in adults with multiple myeloma [15][1].
- RSV vaccine: Newer vaccines that protect against Respiratory Syncytial Virus are inactivated and have been shown to prevent complications in older adults, though your doctor will decide the best time for you to receive it [16].
A Note on Vaccine Side Effects
Because these vaccines are teaching your immune system, you may experience temporary side effects like a sore arm, low-grade fever, or feeling extra tired for a day or two. This is a normal immune response, not a multiple myeloma flare-up or an infection. However, always ask your care team what specific symptoms should prompt a call to their office.
What About Your Family?
It is highly encouraged for your close contacts to be fully vaccinated, a strategy known as cocooning [17]. This creates a protective shield around you. In general, your household members can safely receive most routine vaccines, including the live nasal flu spray and the MMR, as the risk of them passing the weakened virus to you is extremely low [17][18]. One exception is the oral rotavirus vaccine given to infants; careful handwashing and diaper hygiene are required to prevent transmission to you [17].
Timing Matters
While inactivated vaccines are safe, your multiple myeloma treatment can still lower how well they work [19][20]. If you are receiving newer therapies like CAR-T cell therapy or bispecific antibodies, or if you recently had an autologous stem cell transplant (ASCT), vaccines are usually delayed for a few months until your immune system recovers enough to respond [1].
Talk to your doctor about the best time in your treatment cycle to get your vaccines so you get the maximum protection [1].
Pro Tip: Always inform the pharmacist that you have multiple myeloma and are immunocompromised before receiving any shot. This provides an extra layer of safety to ensure you are given the correct inactivated formulation.
Frequently Asked Questions
Which vaccines are safe for multiple myeloma patients?
Why must I avoid live vaccines?
Can my family members safely get vaccinated if I have multiple myeloma?
Does my multiple myeloma treatment affect when I should get vaccinated?
Questions for Your Doctor
- • Based on my current treatment plan and immune markers (like ANC and IgG), when is the optimal time for me to receive my vaccines?
- • Which specific sequence of pneumococcal vaccines do you recommend for me?
- • Should I be tested to see if my past vaccines (titers) are still providing protection?
- • What side effects should I expect after receiving these recommended vaccines, and at what temperature or symptom severity should I call the clinic?
- • Are there any specific vaccines my family members should avoid, or extra precautions we should take if an infant in my family receives the rotavirus vaccine?
Questions for You
- • Do I have a personal record of the dates and types of vaccines I have received since my multiple myeloma diagnosis?
- • Are the people I live with or spend the most time with up to date on their seasonal flu and COVID-19 vaccines?
- • What infections or illnesses have I experienced over the last year, and have I discussed them with my oncologist?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group.
Raje NS, Anaissie E, Kumar SK, et al.
The Lancet. Haematology 2022; (9(2)):e143-e161 doi:10.1016/S2352-3026(21)00283-0.
PMID: 35114152 - 2
Novel Treatment Options for Multiple Myeloma.
Portuguese AJ, Banerjee R, Chen G, et al.
JCO oncology practice 2025; (21(7)):950-961 doi:10.1200/OP-24-00752.
PMID: 39772633 - 3
Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.
Terpos E, Trougakos IP, Gavriatopoulou M, et al.
Blood 2021; (137(26)):3674-3676 doi:10.1182/blood.2021011904.
PMID: 33861315 - 4
Immunotherapeutics for Covid-19 and post vaccination surveillance.
Sampath Kumar NS, Chintagunta AD, Jeevan Kumar SP, et al.
3 Biotech 2020; (10(12)):527 doi:10.1007/s13205-020-02522-9.
PMID: 33200061 - 5
African swine fever vaccines: a promising work still in progress.
Bosch-Camós L, López E, Rodriguez F
Porcine health management 2020; (6()):17 doi:10.1186/s40813-020-00154-2.
PMID: 32626597 - 6
IL-10 inducible CD8+ regulatory T-cells are enriched in patients with multiple myeloma and impact the generation of antigen-specific T-cells.
Plaumann J, Engelhardt M, Awwad MHS, et al.
Cancer immunology, immunotherapy : CII 2018; (67(11)):1695-1707 doi:10.1007/s00262-018-2230-0.
PMID: 30128739 - 7
The Evolving Role of Checkpoint Inhibitors in Multiple Myeloma.
Chakrabarti R, Siegel D, Biran N
Clinical lymphoma, myeloma & leukemia 2025; (25(2)):96-108 doi:10.1016/j.clml.2024.08.004.
PMID: 39261126 - 8
Immune Response to Vaccination in Patients with Psoriasis Treated with Systemic Therapies.
Chiricozzi A, Gisondi P, Bellinato F, Girolomoni G
Vaccines 2020; (8(4)) doi:10.3390/vaccines8040769.
PMID: 33339348 - 9
Live Vaccine and Varicella Postexposure Prophylaxis in Pediatric Liver Transplant Recipients: A Survey of Practice in Australia and New Zealand.
Bonett E, Doyle R, Roberts A, Wen SCH
Pediatric transplantation 2024; (28(5)):e14833 doi:10.1111/petr.14833.
PMID: 39039719 - 10
Bacterial vaccines in poultry.
Rabie NS, Amin Girh ZMS
Bulletin of the National Research Centre 2020; (44(1)):15 doi:10.1186/s42269-019-0260-1.
PMID: 32435127 - 11
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).
Cordonnier C, Einarsdottir S, Cesaro S, et al.
The Lancet. Infectious diseases 2019; (19(6)):e200-e212 doi:10.1016/S1473-3099(18)30600-5.
PMID: 30744963 - 12
Tuberculosis vaccination: microbiological and immunological summary of a series of experimental challenge studies.
Juste RA, Sevilla IA, Minguijon E, et al.
Veterinary research 2025; (56(1)):202 doi:10.1186/s13567-025-01637-2.
PMID: 41137142 - 13
COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review.
Faizan U, Nair LG, Bou Zerdan M, et al.
Therapeutic advances in vaccines and immunotherapy 2023; (11()):25151355231190497 doi:10.1177/25151355231190497.
PMID: 37645011 - 14
Management of patients with multiple myeloma and COVID-19 in the post pandemic era: a consensus paper from the European Myeloma Network (EMN).
Terpos E, Musto P, Engelhardt M, et al.
Leukemia 2023; (37(6)):1175-1185 doi:10.1038/s41375-023-01920-1.
PMID: 37142661 - 15
Whole-body MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging for the staging of multiple myeloma.
Dutoit JC, Verstraete KL
Skeletal radiology 2017; (46(6)):733-750 doi:10.1007/s00256-017-2609-6.
PMID: 28289855 - 16
Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis.
Payne AB, Watts JA, Mitchell PK, et al.
Lancet (London, England) 2024; (404(10462)):1547-1559 doi:10.1016/S0140-6736(24)01738-0.
PMID: 39426837 - 17
Vaccination Status in Pediatric Solid-Organ Transplant Recipients and Their Household Members.
Cortina G, Ojinaga V, Zlamy M, et al.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2019; (17(4)):429-434 doi:10.6002/ect.2018.0184.
PMID: 31050613 - 18
Acceptance of SARS-CoV-2 vaccines by liver transplant recipients and candidates.
Reuken PA, Albers S, Rauchfuss F, et al.
Zeitschrift fur Gastroenterologie 2021; (59(12)):1288-1296 doi:10.1055/a-1649-8568.
PMID: 34670294 - 19
Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy.
Bemben NM, Berg ML
Pharmacotherapy 2022; (42(4)):334-342 doi:10.1002/phar.2671.
PMID: 35146780 - 20
Concentrations of Adalimumab and Infliximab in Mothers and Newborns, and Effects on Infection.
Julsgaard M, Christensen LA, Gibson PR, et al.
Gastroenterology 2016; (151(1)):110-9.
PMID: 27063728
This page provides educational information about vaccine safety for multiple myeloma patients. Always consult your oncologist or pharmacist before receiving any vaccination to ensure it is appropriate for your specific treatment plan and immune status.
Stay up to date
Get notified when new research about Multiple Myeloma is published.
No spam. Unsubscribe anytime.